RE:RE:RE:RE:RE:RE:RE:RE:RE:TpGI'm not short, but these articles are quickly changing my outlook. It was easier to ignore the Financial Times article as it looked like a puff piece for the shorts, but The Times and The Daily Mail articles just released clearly put the Amdipharm business in the crosshairs of the UK government. This is becoming alot harder to ignore and could have very real implications for profitability. Not a great position to be in given the companies heavy debtload. The uncertainty alone could kill sentiment.
Hateshorts wrote:
yes I would.. tpg was will to take a risk with valent shorty